Project Description

What they do:

Gene Tox Lab Solutions, Inc. is in the genetic testing, precision medicine, and analytics market. To perform genetic testing, analysis, interpretation, and implementation for providers and their patients to improve clinical outcomes, Gene Tox Lab Solutions (GTLS) has created a HIPAA-compliant platform for numerous commercial markets in the U.S. that seamlessly manages the entire genetics testing process for the customer, patient, and primary care provider. This patent-pending software can also identify patients most at risk and who would more likely benefit from genetic testing. After testing is complete, GTLS offers genetic counseling and education to both physicians and patients.

Why we invested:

Driven by the concept of servant leadership, Co-founders Catherine Rells, Dr. Steven Ross, and Dr. James Padilla set out to improve health outcomes one individual at a time. Gene Tox Lab Solutions plans to serve underinvested communities, with the goal of training and employing an inclusive workforce, bringing quality jobs to our region.

Learn more about Gene Tox Lab Solutions on their website.

 

← Back to Portfolio

Project Details

  • Impact SegmentImproving health outcomes; shaping markets; creating quality jobs
  • Impact VehicleAdvance
  • Investment Details$150,000 loan made in August 2020
  • Impact GeographySan Diego, CA; nationwide
  • LeadershipCatherine Rells, CEO; Dr. Steven Ross, Chief Medical Officer; Dr. James Padilla, Chief Strategy Officer
  • Year Founded2018